CNMD Stock Overview
A medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
CONMED Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$68.63 |
| 52 Week High | US$114.80 |
| 52 Week Low | US$61.05 |
| Beta | 1.47 |
| 1 Month Change | -8.38% |
| 3 Month Change | -9.10% |
| 1 Year Change | -39.20% |
| 3 Year Change | -51.68% |
| 5 Year Change | -37.87% |
| Change since IPO | 3,331.50% |
Recent News & Updates
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20
Dec 13
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Nov 25CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem
Nov 07Recent updates
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20
Dec 13Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Nov 25CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem
Nov 07Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 02Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?
Oct 01Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price
Sep 12CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20
Aug 15CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price
Jul 17AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Jun 21There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding
Jun 01Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15Shareholder Returns
| CNMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -5.4% | -1.5% | -2.4% |
| 1Y | -39.2% | 10.0% | 23.4% |
Return vs Industry: CNMD underperformed the US Medical Equipment industry which returned 10.1% over the past year.
Return vs Market: CNMD underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| CNMD volatility | |
|---|---|
| CNMD Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CNMD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CNMD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 4,000 | Curt Hartman | www.conmed.com |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
CONMED Corporation Fundamentals Summary
| CNMD fundamental statistics | |
|---|---|
| Market cap | US$2.12b |
| Earnings (TTM) | US$131.74m |
| Revenue (TTM) | US$1.29b |
16.1x
P/E Ratio1.6x
P/S RatioIs CNMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNMD income statement (TTM) | |
|---|---|
| Revenue | US$1.29b |
| Cost of Revenue | US$569.15m |
| Gross Profit | US$718.96m |
| Other Expenses | US$587.22m |
| Earnings | US$131.74m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.26 |
| Gross Margin | 55.82% |
| Net Profit Margin | 10.23% |
| Debt/Equity Ratio | 100.6% |
How did CNMD perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield19%
Payout RatioDoes CNMD pay a reliable dividends?
See CNMD dividend history and benchmarks| CONMED dividend dates | |
|---|---|
| Ex Dividend Date | Dec 20 2024 |
| Dividend Pay Date | Jan 03 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 12 days |
Does CNMD pay a reliable dividends?
See CNMD dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:54 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CONMED Corporation is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | Barclays |
| Travis Steed | BofA Global Research |
| Kristen Stewart | CL King & Associates, Inc. |